JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SC
2626
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $3.12M | ﹤0.01% |
244,788
+243,495
| +18,832% | +$2.95M |
2014 Q1
13 quarters
|
|
2627
Magnite
MGNI
$3.56B
| $3.12M | ﹤0.01% |
607,287
+41,093
| +7% | +$226K |
2014 Q2
12 quarters
|
|
2628
PUT
US Bancorp Series B Preferred Stock
USB.PRH
$731M
| $3.12M | ﹤0.01% |
60,100
-12,800
| -18% | -$302K |
2016 Q4
2 quarters
|
|
2629
CALL
Zions Bancorporation
ZION
$9.17B
| $3.12M | ﹤0.01% |
+71,000
| New | +$2.92M |
2017 Q2
0 quarters
|
|
2630
Encore Capital Group
ECPG
$2.1B
| $3.12M | ﹤0.01% |
77,640
+17,543
| +29% | +$630K |
2013 Q2
16 quarters
|
|
|
LGF.A
2631
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $3.12M | ﹤0.01% |
110,362
-154,429
| -58% | -$4.06M |
2016 Q4
2 quarters
|
|
|
CSOD
2632
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $3.12M | ﹤0.01% |
87,137
-193,389
| -69% | -$7.24M |
2013 Q2
16 quarters
|
|
2633
Vanguard Total World Stock ETF
VT
$82B
| $3.1M | ﹤0.01% |
45,860
-79,651
| -63% | -$5.33M |
2013 Q4
14 quarters
|
|
2634
CALL
NRG Energy
NRG
$21.8B
| $3.08M | ﹤0.01% |
178,700
| – | – |
2017 Q1
1 quarter
|
|
|
CVGW
2635
DELISTED
Calavo Growers
CVGW
| $3.07M | ﹤0.01% |
44,490
-82,988
| -65% | -$5.59M |
2013 Q2
16 quarters
|
|
2636
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.1B
| $3.07M | ﹤0.01% |
106,306
+12,448
| +13% | +$356K |
2016 Q1
5 quarters
|
|
2637
Vanguard Intermediate-Term Bond ETF
BIV
$28B
| $3.07M | ﹤0.01% |
36,265
+6,888
| +23% | +$582K |
2015 Q1
9 quarters
|
|
2638
ASE Group
ASX
$122B
| $3.06M | ﹤0.01% |
484,721
+145,800
| +43% | +$913K |
2013 Q2
16 quarters
|
|
2639
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.55B
| $3.05M | ﹤0.01% |
97,705
+822
| +0.8% | +$26.2K |
2013 Q2
16 quarters
|
|
2640
PJT Partners
PJT
$3.57B
| $3.04M | ﹤0.01% |
75,647
+22,206
| +42% | +$831K |
2015 Q4
6 quarters
|
|
|
UMH
2641
UMH Properties
UMH
$1.32B
| $3.04M | ﹤0.01% |
178,469
+53,511
| +43% | +$882K |
2014 Q4
10 quarters
|
|
|
MNDT
2642
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $3.04M | ﹤0.01% |
200,000
| – | – |
2017 Q1
1 quarter
|
|
2643
Peoples Bancorp
PEBO
$1.32B
| $3.03M | ﹤0.01% |
94,391
-5,562
| -6% | -$179K |
2016 Q4
2 quarters
|
|
|
ABAX
2644
DELISTED
Abaxis Inc
ABAX
| $3.03M | ﹤0.01% |
57,144
-48,312
| -46% | -$2.38M |
2015 Q4
6 quarters
|
|
|
PDLI
2645
DELISTED
PDL BioPharma, Inc.
PDLI
| $3.02M | ﹤0.01% |
1,223,658
-549,767
| -31% | -$1.26M |
2013 Q2
16 quarters
|
|
2646
Seres Therapeutics
MCRB
$29.1M
| $3.02M | ﹤0.01% |
13,343
-5,168
| -28% | -$1.06M |
2015 Q2
8 quarters
|
|
2647
Workiva
WK
$3.82B
| $3.02M | ﹤0.01% |
158,336
+142,595
| +906% | +$2.52M |
2016 Q4
2 quarters
|
|
|
ASXC
2648
DELISTED
Asensus Surgical, Inc.
ASXC
| $3M | ﹤0.01% |
325,613
+213
| +0.1% | +$2.03K |
2015 Q2
8 quarters
|
|
2649
National Grid
NGG
$77.3B
| $2.99M | ﹤0.01% |
53,884
-188,832
| -78% | -$11.5M |
2013 Q2
16 quarters
|
|
|
NIHD
2650
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $2.99M | ﹤0.01% |
3,721,872
-23,320
| -0.6% | -$17.8K |
2015 Q3
7 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.